4//SEC Filing
Lipocine Inc. 4
Accession 0001144204-15-032029
$LPCNCIK 0001535955operating
Filed
May 17, 8:00 PM ET
Accepted
May 18, 4:47 PM ET
Size
5.3 KB
Accession
0001144204-15-032029
Insider Transaction Report
Form 4
Lipocine Inc.LPCN
Mattila Jyrki
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2015-05-15+80,000→ 80,000 totalExercise: $7.66Exp: 2025-05-14→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary date of May 15, 2016, with the remaining 2/3 of the shares vesting monthly on a pro-rata basis over the following two years.
Documents
Issuer
Lipocine Inc.
CIK 0001535955
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001535955
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 4:47 PM ET
- Size
- 5.3 KB